• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病对息肉切除术后结直肠腺瘤性息肉复发风险的影响。

Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy.

机构信息

Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Korean J Intern Med. 2021 May;36(3):557-567. doi: 10.3904/kjim.2019.360. Epub 2020 Jul 7.

DOI:10.3904/kjim.2019.360
PMID:32630984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8137416/
Abstract

BACKGROUND/AIMS: Metabolic syndrome has been reported to be a risk factor for metachronous colorectal neoplasia (CRN). However, the impact of nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic syndrome, on the development of metachronous CRN after polypectomy has been rarely examined. We evaluated the association between NAFLD and the development of metachronous CRN after polypectomy.

METHODS

Asymptomatic subjects who underwent abdominal ultrasonography and endoscopic removal of ≥ 1 adenomas at the index colonoscopy between 2010 and 2014, and had a follow-up surveillance colonoscopy until 2017 were analyzed.

RESULTS

Of 6,182 participants, 2,642 (42.7%) had NAFLD at the time of the index colonoscopy. Patients with NAFLD had significantly higher cumulative incidence rates of metachronous overall CRN than those without NAFLD in both men (19.4% vs. 18.2% at 3 years and 49.2% vs. 44.0% at 5 years; p = 0.001) and women (18.7% vs. 10.5% at 3 years and 56.1% vs. 29.8% at 5 years; p < 0.001). Even after adjusting for confounders, NAFLD remained independently associated with an increased risk of metachronous overall CRN in both men (adjusted hazard ratio [HR], 1.17; 95% confidence interval [CI], 1.06 to 1.29) and women (adjusted HR, 1.63; 95% CI, 1.27 to 2.07). Additionally, NAFLD was an independent risk factor for metachronous advanced CRN (ACRN) in women (adjusted HR, 2.61; 95% CI, 1.27 to 5.37).

CONCLUSION

NAFLD is related to an increased risk of metachronous CRN after polypectomy. Especially, women with NAFLD are at an increased risk of developing metachronous ACRN. Our results indicate a possible effect of NAFLD on the pathogenesis of CRN.

摘要

背景/目的:代谢综合征已被报道为结直肠腺瘤复发(CRN)的危险因素。然而,代谢综合征的肝脏表现——非酒精性脂肪性肝病(NAFLD)对息肉切除术后发生异时性 CRN 的影响很少被研究。我们评估了 NAFLD 与息肉切除术后异时性 CRN 发展之间的关系。

方法

分析了 2010 年至 2014 年间在指数结肠镜检查中接受腹部超声和内镜下切除≥1 个腺瘤且在 2017 年之前进行随访结肠镜检查的无症状受试者。

结果

在 6182 名参与者中,2642 名(42.7%)在指数结肠镜检查时患有 NAFLD。在男性(3 年时为 19.4%比 18.2%,5 年时为 49.2%比 44.0%;p = 0.001)和女性(3 年时为 18.7%比 10.5%,5 年时为 56.1%比 29.8%;p < 0.001)中,患有 NAFLD 的患者异时性总体 CRN 的累积发生率明显高于不患有 NAFLD 的患者。即使在调整混杂因素后,NAFLD 仍然与男性(调整后的危险比[HR],1.17;95%置信区间[CI],1.06 至 1.29)和女性(调整后的 HR,1.63;95%CI,1.27 至 2.07)中异时性总体 CRN 的风险增加独立相关。此外,NAFLD 是女性异时性高级 CRN(ACRN)的独立危险因素(调整后的 HR,2.61;95%CI,1.27 至 5.37)。

结论

NAFLD 与息肉切除术后异时性 CRN 的风险增加有关。特别是,患有 NAFLD 的女性发生异时性 ACRN 的风险增加。我们的结果表明,NAFLD 可能对 CRN 的发病机制有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c341/8137416/61295075fc22/kjim-2019-360f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c341/8137416/35515a3d8377/kjim-2019-360f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c341/8137416/06042815adb2/kjim-2019-360f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c341/8137416/61295075fc22/kjim-2019-360f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c341/8137416/35515a3d8377/kjim-2019-360f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c341/8137416/06042815adb2/kjim-2019-360f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c341/8137416/61295075fc22/kjim-2019-360f3.jpg

相似文献

1
Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy.非酒精性脂肪性肝病对息肉切除术后结直肠腺瘤性息肉复发风险的影响。
Korean J Intern Med. 2021 May;36(3):557-567. doi: 10.3904/kjim.2019.360. Epub 2020 Jul 7.
2
Changes in Abdominal Obesity Affect the Risk of Metachronous Advanced Colorectal Neoplasia Development after Polypectomy.腹部肥胖的变化会影响息肉切除术后同时性高级结直肠肿瘤发展的风险。
Yonsei Med J. 2020 Jul;61(7):579-586. doi: 10.3349/ymj.2020.61.7.579.
3
Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged < 50 years.家族史与<50 岁患者息肉切除术后结直肠腺瘤复发风险的相关性。
J Gastroenterol Hepatol. 2019 Feb;34(2):383-389. doi: 10.1111/jgh.14578. Epub 2019 Jan 6.
4
Impact of obesity and metabolic abnormalities on the risk of metachronous colorectal neoplasia after polypectomy in men.肥胖和代谢异常对男性息肉切除术后异时性结直肠新生物风险的影响。
J Gastroenterol Hepatol. 2019 Sep;34(9):1504-1510. doi: 10.1111/jgh.14702. Epub 2019 Jun 7.
5
Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps.根据脂肪肝严重程度和胆囊息肉情况评估结直肠肿瘤发生风险
Dig Dis Sci. 2016 Jan;61(1):317-24. doi: 10.1007/s10620-015-3873-8. Epub 2015 Sep 18.
6
Effect of Cotinine-Verified Change in Smoking Status on Risk of Metachronous Colorectal Neoplasia After Polypectomy.基于可替宁验证的吸烟状态改变对息肉切除术后结直肠腺瘤复发风险的影响。
Clin Gastroenterol Hepatol. 2020 Jan;18(1):163-170. doi: 10.1016/j.cgh.2019.02.018. Epub 2019 Feb 14.
7
Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms.总的息肉数量可能比息肉的大小和组织学更重要,可用于预测同时发生的高风险结直肠肿瘤。
BMC Gastroenterol. 2022 Mar 2;22(1):91. doi: 10.1186/s12876-022-02177-1.
8
Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.非酒精性脂肪性肝病对结直肠肿瘤发生的临床影响:倾向评分匹配分析
PLoS One. 2017 Aug 4;12(8):e0182014. doi: 10.1371/journal.pone.0182014. eCollection 2017.
9
Risk of developing metachronous advanced colorectal neoplasia after colonoscopic polypectomy in patients aged 30 to 39 and 40 to 49 years.30 至 39 岁和 40 至 49 岁患者结肠镜息肉切除术后发生异时性晚期结直肠肿瘤的风险。
Gastrointest Endosc. 2018 Oct;88(4):715-723. doi: 10.1016/j.gie.2018.05.018. Epub 2018 May 29.
10
Risk of developing metachronous colorectal neoplasia after the resection of proximal versus distal adenomas.近端腺瘤与远端腺瘤切除术后发生异时性结直肠肿瘤的风险。
Dig Liver Dis. 2022 Apr;54(4):537-542. doi: 10.1016/j.dld.2021.08.005. Epub 2021 Aug 22.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease in the Korean General Population: Epidemiology, Risk Factors, and Non-Invasive Screening.韩国普通人群中代谢功能障碍相关脂肪性肝病:流行病学、危险因素及非侵入性筛查
Metabolites. 2025 Apr 30;15(5):299. doi: 10.3390/metabo15050299.
2
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.绝经后女性的代谢功能障碍相关脂肪性肝病:患病率、发病机制及基于性别的治疗方法
Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855.
3
Established nomogram based on clinicopathological characteristics, lifestyle, and comorbidities risk factors for metachronous recurrence in curative endoscopic submucosal dissection.

本文引用的文献

1
The Fatty Liver Index: A Simple and Accurate Predictor of Colorectal Adenoma in an Average-Risk Population.脂肪肝指数:普通风险人群中结直肠腺瘤的简单准确预测指标。
Dis Colon Rectum. 2018 Jan;61(1):36-42. doi: 10.1097/DCR.0000000000000973.
2
Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.非酒精性脂肪性肝病对结直肠肿瘤发生的临床影响:倾向评分匹配分析
PLoS One. 2017 Aug 4;12(8):e0182014. doi: 10.1371/journal.pone.0182014. eCollection 2017.
3
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.
基于临床病理特征、生活方式和合并症的已建立的列线图,用于治愈性内镜黏膜下剥离术后异时性复发的风险评估。
Therap Adv Gastroenterol. 2025 Apr 14;18:17562848251330973. doi: 10.1177/17562848251330973. eCollection 2025.
4
Comorbidities related to metachronous recurrence for early gastric cancer in elderly patients.老年早期胃癌异时性复发相关的合并症
World J Gastrointest Endosc. 2025 Mar 16;17(3):99540. doi: 10.4253/wjge.v17.i3.99540.
5
Association between metabolic dysfunction-associated steatotic liver disease and risk of colorectal cancer or colorectal adenoma: an updated meta-analysis of cohort studies.代谢功能障碍相关脂肪性肝病与结直肠癌或结直肠腺瘤风险之间的关联:队列研究的最新荟萃分析
Front Oncol. 2024 Jul 9;14:1368965. doi: 10.3389/fonc.2024.1368965. eCollection 2024.
6
Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms.非酒精性脂肪性肝病与结直肠肿瘤风险之间的相关性分析。
Front Pharmacol. 2022 Nov 9;13:1068432. doi: 10.3389/fphar.2022.1068432. eCollection 2022.
7
Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep's Clothing?非酒精性脂肪性肝病与肝外癌症:披着羊皮的狼?
Curr Oncol. 2022 Jun 25;29(7):4478-4510. doi: 10.3390/curroncol29070356.
结直肠癌筛查:美国多学会专家组对医生和患者的建议。
Am J Gastroenterol. 2017 Jul;112(7):1016-1030. doi: 10.1038/ajg.2017.174. Epub 2017 Jun 6.
4
Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.非酒精性脂肪性肝病与结直肠肿瘤风险。
Aliment Pharmacol Ther. 2017 Jan;45(2):345-353. doi: 10.1111/apt.13866. Epub 2016 Nov 18.
5
Non-alcoholic fatty liver disease and colorectal cancer.非酒精性脂肪性肝病与结直肠癌
Postgrad Med J. 2017 Mar;93(1097):153-158. doi: 10.1136/postgradmedj-2016-134383. Epub 2016 Nov 16.
6
Metabolic syndrome is a risk factor for adenoma occurrence at surveillance colonoscopy: A single-center experience in Korea.代谢综合征是监测结肠镜检查时腺瘤发生的危险因素:韩国的单中心经验。
Medicine (Baltimore). 2016 Aug;95(32):e4454. doi: 10.1097/MD.0000000000004454.
7
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.非酒精性脂肪性肝病与肝外癌症
Int J Mol Sci. 2016 May 12;17(5):717. doi: 10.3390/ijms17050717.
8
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.代谢健康型肥胖与非酒精性脂肪性肝病的发生发展
Am J Gastroenterol. 2016 Aug;111(8):1133-40. doi: 10.1038/ajg.2016.178. Epub 2016 May 17.
9
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
10
NAFLD: a multisystem disease.非酒精性脂肪性肝病:一种多系统疾病。
J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012.